About Mviyes Pharma Ventures Private Limited
Data last updated: 23 July 2025
Mviyes Pharma Ventures Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Aurobindo Pharma Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 30 March 2017.
Registered with ROC Hyderabad under CIN U74999TG2017PTC116265.
Capital: an authorised share capital of ₹150.25 Cr and a paid-up capital of ₹150.25 Cr. It was led by directors including Sapna and Madadi Venkat Reddy.
Last AGM: 19 June 2023. Financial statements filed for year ended 31 March 2023. Office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2023, the company reported a revenue of ₹20.38 Lakh, reflecting significant growth compared to the previous year.
It operated as a subsidiary of Aurobindo Pharma Ltd.
The company was associated with 1 brand - Aurobindo Pharma. As per MCA filings, the company had satisfied charges of ₹675 Cr on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is aurobindo.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Mviyes Pharma Ventures Private Limited
Mviyes Pharma Ventures Private Limited operates one associated brand: Aurobindo Pharma. These brands represent Mviyes Pharma Ventures Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com |
Competitors & Alternatives of Mviyes Pharma Ventures Private Limited
Brands and companies operating in the same space as Mviyes Pharma Ventures Private Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Biophore
|
Niche generic pharmaceuticals are developed and manufactured for industry needs. | Hyderabad, India, India | 2007 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Mviyes Pharma Ventures Private Limited
Mviyes Pharma Ventures Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Mviyes Pharma Ventures Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Mviyes Pharma Ventures Private Limited
Mviyes Pharma Ventures Private Limited is audited by G P M & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Mviyes Pharma Ventures Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Mviyes Pharma Ventures Private Limited
Mviyes Pharma Ventures Private Limited currently reports 3 directors and 1 key managerial person. 14 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Thomas Koshy Vellutheril
Also directs:
Auroactive Pharma Private Limited, Auro Pharma Limited
|
Cfo | 01 Jul 2021 | 5 Years 1 Months | As last reported |
|
Sapna
Also directs:
Aurigene Pharmaceutical Services Limited
|
Director | 23 Oct 2020 | 5 Years 10 Months | As last reported |
| Madadi Venkat Reddy | Whole-Time Director | 01 Jul 2021 | 5 Years 1 Months | As last reported |
|
Suryanarayana Murthy Mula
Also directs:
Apl Healthcare Limited, Aurozest Private Limited
|
Director | 23 Oct 2020 | 5 Years 10 Months | As last reported |
Financials of Mviyes Pharma Ventures Private Limited FY 2023 filings available
Mviyes Pharma Ventures Private Limited reported revenue of ₹20.38 Lakh (up 477.00% YoY) for FY 2023.
Ten-year financial statements for Mviyes Pharma Ventures Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Mviyes Pharma Ventures Private Limited
Shareholding and ownership data for Mviyes Pharma Ventures Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mviyes Pharma Ventures Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2019 | Others | ₹675 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Mviyes Pharma Ventures Private Limited
View historical data on people associated with Mviyes Pharma Ventures Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Mviyes Pharma Ventures Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Mviyes Pharma Ventures Private Limited
GST registrations and filing compliance for Mviyes Pharma Ventures Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Mviyes Pharma Ventures Private Limited
Credit ratings, litigation, and regulatory alerts for Mviyes Pharma Ventures Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mviyes Pharma Ventures Private Limited
MSME payment history for Mviyes Pharma Ventures Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mviyes Pharma Ventures Private Limited
Corporate group structure for Mviyes Pharma Ventures Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mviyes Pharma Ventures Private Limited
MCA filings and documents for Mviyes Pharma Ventures Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Mviyes Pharma Ventures Private Limited
Frequently Asked Questions about Mviyes Pharma Ventures Private Limited
Mviyes Pharma Ventures Private Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Mviyes Pharma Ventures Private Limited is a amalgamated private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 30 March 2017 and is registered under CIN U74999TG2017PTC116265. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Mviyes Pharma Ventures Private Limited was incorporated on 30 March 2017. Registered with ROC Hyderabad.
The current directors and KMP of Mviyes Pharma Ventures Private Limited are:
- Thomas Koshy Vellutheril - Cfo
- Sapna - Director
- Madadi Venkat Reddy - Whole-Time Director
- Suryanarayana Murthy Mula - Director
The CIN (Corporate Identification Number) of Mviyes Pharma Ventures Private Limited is U74999TG2017PTC116265. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Mviyes Pharma Ventures Private Limited is pharma. The company specifically operates in drug formulation and development.